A Lifetime of Lung Health: A Global Call to Action for World Lung Day 2026 on September 28, 2026 Posted by
A Legacy of Defiance: How the Victoria Ann Michelis Fund is Reshaping Ovarian Cancer Research on September 28, 2026 Posted by
The Cool Cove Revolution: A Comprehensive Evaluation of the 2-in-1 Portable Climate Control Solution on September 28, 2026 Posted by
The Future of Surgery: FDA Charts a New Regulatory Course for Autonomous and Telesurgical Robotics on September 28, 2026 Posted by
Elevating Standards in Pain Management: Dr. Ball Achieves Prestigious Medidata Certification on September 28, 2026 Posted by
Beyond the Stigma: Understanding the Evolution and Impact of National Recovery Month on September 28, 2026 Posted by
Wandercraft’s Groundbreaking Eve Exoskeleton Launches in U.S., Offering Unprecedented Hands-Free Mobility on September 28, 2026 Posted by
A Lifetime of Lung Health: A Global Call to Action for World Lung Day 2026 on September 28, 2026 Posted by
A Legacy of Defiance: How the Victoria Ann Michelis Fund is Reshaping Ovarian Cancer Research on September 28, 2026 Posted by
The Cool Cove Revolution: A Comprehensive Evaluation of the 2-in-1 Portable Climate Control Solution on September 28, 2026 Posted by
The Future of Surgery: FDA Charts a New Regulatory Course for Autonomous and Telesurgical Robotics on September 28, 2026 Posted by
Posted in Medical Innovations A New Era for RNAi: ADARx Pharmaceuticals Breaks Decade-Long IPO Drought on September 27, 2026
Posted in Digital Health Tools ADARx Pharmaceuticals Secures $535M in Blockbuster IPO to Advance RNA Interference Pipeline on September 26, 2026
Posted in Digital Health Tools ADARx Pharmaceuticals Secures $535M in Blockbuster IPO to Advance Next-Generation RNA Interference Pipeline on September 25, 2026
Posted in Medical Innovations RNA Therapeutics Rebound: ADARx Pharmaceuticals Leads a Rare IPO Surge on September 25, 2026
Posted in Medical Innovations ADARx Pharmaceuticals Breaks Decade-Long Stagnation with Landmark RNAi IPO on September 25, 2026
Posted in Digital Health Tools Telix Pharmaceuticals Seals $1.65 Billion Deal for ITM, Cementing Dominance in the Radiopharmaceutical Arms Race on September 21, 2026
Posted in Medical Innovations The Billion-Dollar Bet: Telix Pharmaceuticals and ITM Join Forces to Redefine Radiopharmaceuticals on September 21, 2026
Posted in Medical Innovations Xenon Pharmaceuticals Faces Investor Volatility as Depression Trial Pause Clouds Epilepsy Outlook on September 18, 2026
Posted in Digital Health Tools A Breakthrough for the Ultra-Rare: FDA Grants Historic Approval to Ionis Pharmaceuticals for Alexander Disease Treatment on September 4, 2026
Posted in Medical Innovations A New Dawn for Rare Disease: Ionis Pharmaceuticals Secures Historic FDA Approval for Alexander Disease Therapy on September 3, 2026
